Intravesical Prostatic Protrusion Does Not Influence the Efficacy of Prostatic Artery Embolization
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging
Reference18 articles.
1. Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years' experience;Carnevale;Radiol,2020
2. Outcome prediction of prostatic artery embolization: post hoc analysis of a randomized, open-label, non-inferiority trial;Abt;BJU Int,2019
3. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population;Wang;BMC Urol,2015
4. A review of adverse events related to prostatic artery embolization for treatment of bladder outlet obstruction due to BPH;Moreira;Cardiovasc Intervent Radiol,2017
5. Intravesical prostatic protrusion can be a predicting factor for the treatment outcome in patients with lower urinary tract symptoms due to benign prostatic obstruction treated with tamsulosin;Cumpanas;J Urol,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prostate Artery Embolization for Benign Prostatic Hyperplasia;Journal of Urology;2024-07
2. A correlation study between prostate necrosis rate calculated by 3D Slicer software and clinical efficacy of prostatic artery embolization, along with an analysis of predictors of clinical success after prostatic artery embolization;Abdominal Radiology;2023-12-29
3. Prostatic Arterial Embolization for Treatment of Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement;Current Urology Reports;2023-06-14
4. The prostatic middle lobe: clinical significance, presentation and management;Nature Reviews Urology;2023-05-15
5. Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization;CVIR Endovascular;2023-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3